comparemela.com

Latest Breaking News On - Stringent regulatory authority - Page 8 : comparemela.com

Africa s long wait for the Covid-19 vaccine

Africa s long wait for the Covid-19 vaccine By Anne Soy image copyrightSOPA Images Africa will have to wait weeks if not months before receiving Covid-19 vaccines approved by the World Health Organization, according to various officials working towards getting doses for the continent. Close to 900 million doses have been secured so far through various initiatives, enough to inoculate about 30% of the continent s 1.3 billion people this year. Hoarding by wealthy nations, funding shortfalls, regulations and cold chain requirements have slowed the process of rolling out the vaccines. The world is on the brink of a catastrophic moral failure and the price will be paid with lives and livelihoods in the poorest countries, warned WHO head Dr Tedros Ghebreyesus.

$9 Billion ADB Facility to Help Members Access and Distribute COVID-19 Vaccines

$9 Billion ADB Facility to Help Members Access and Distribute COVID-19 Vaccines Promoting safe, equitable, and effective access to vaccines is a top priority for ADB’s COVID-19 response efforts. Vaccination programs can break the chain of virus transmission, save lives, and mitigate the negative economic impacts of the pandemic by restoring confidence in people’s ability to work, travel, and socialize safely. Source: Global News Tuesday, 15 December 2020 10:05 AM The Asian Development Bank (ADB) has launched a $9 billion vaccine initiative the Asia Pacific Vaccine Access Facility (APVAX) offering rapid and equitable support to its developing members as they procure and deliver effective and safe coronavirus disease (COVID-19) vaccines.

USD9Bn ADB facility to help members access and distribute COVID-19 vaccines

Posted on The Asian Development Bank (ADB) has launched a $9 billion vaccine initiative the Asia Pacific Vaccine Access Facility (APVAX) offering rapid and equitable support to its developing members as they procure and deliver effective and safe coronavirus disease (COVID-19) vaccines. “As ADB’s developing members prepare to vaccinate their people as soon as possible, they need financing to procure vaccines as well as appropriate plans and knowledge to be able to safely, equitably, and efficiently manage the vaccination process,” said ADB President Masatsugu Asakawa. “APVAX will play a critical role in helping our developing members meet these challenges, overcome the pandemic, and focus on economic recovery.”

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.